Johns Hopkins University: Clinical Trials

2,508 trials sponsored by Johns Hopkins University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1475 completed, 333 recruiting, 211 terminated, 183 withdrawn. 1190 Not applicable, 394 Phase 2, 249 Phase 1, 131 Phase 3, 131 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1190Completed 731, Recruiting 147, Terminated 92, Withdrawn 90, Active not recruiting 60, Not yet recruiting 31, Enrolling by invitation 17, Unknown 17, Suspended 5
Phase 2394Completed 229, Recruiting 54, Terminated 45, Withdrawn 24, Active not recruiting 18, Not yet recruiting 13, Unknown 9, Enrolling by invitation 1, Suspended 1
Phase 1249Completed 147, Recruiting 34, Terminated 28, Withdrawn 19, Not yet recruiting 9, Active not recruiting 7, Enrolling by invitation 2, Unknown 2, Suspended 1
Phase 3131Completed 88, Recruiting 20, Active not recruiting 7, Terminated 7, Withdrawn 6, Unknown 2, Not yet recruiting 1
Phase 4131Completed 76, Withdrawn 18, Terminated 15, Recruiting 12, Active not recruiting 4, Not yet recruiting 3, Enrolling by invitation 2, Unknown 1
Early Phase 151Completed 24, Withdrawn 9, Recruiting 6, Terminated 5, Active not recruiting 4, Not yet recruiting 3

Follow Johns Hopkins University: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety
NextGen automated tracheostomy suctioning device, NextGen mixed-reality tracheostomy tube change system, NextGen Tracheostomy Toolkit - Tracheostomy
Not applicableNot yet recruitingJohns Hopkins University6322027-10-012024-02-01
Behavioral Pharmacology of THC and Beta-Myrcene
Placebo, THC, Beta-Myrcene - Cannabis Use
Phase 1Not yet recruitingJohns Hopkins University322027-07-012026-07-31
Inpatient Buprenorphine Induction With Psilocybin for Opioid Use Disorder
Psilocybin - Opioid Use Disorder
Phase 2WithdrawnJohns Hopkins University2027-04-012026-02-23
The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of Psilocybin
0mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 1mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink, 5mg Psilocybin Capsule + 0.00% BAC Alcoholic Drink - Psilocybin Intoxication
Phase 1Not yet recruitingJohns Hopkins University802027-03-012026-10-16
Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
Mouth Tape - Mild Obstructive Sleep Apnea, Snoring
Phase 2RecruitingJohns Hopkins University1002027-03-012026-06-23
Effects of Cannabidiol (CBD) on a Fixed Dose of Delta-9-tetrahydrocannabinol (THC)
0mg THC + 0mg CBD Brownie, 10mg THC + 0mg CBD Brownie, 10mg THC + 10mg CBD Brownie - Cannabis Intoxication
Phase 1Not yet recruitingJohns Hopkins University702027-02-012026-10-15
Project HOPE (Hypertension Outreach Through Partnership and Engagement)
Project HOPE Intervention - Hypertension (HTN)
Not yet recruitingJohns Hopkins University1502027-02-012026-09-08
Study of Bedroom Environment Sleep Intervention at Home for Older Adults Living Alone With Memory Concerns
Bedroom Environment Tailoring, Sleep Health Education - Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI)
Not applicableNot yet recruitingJohns Hopkins University402027-02-012026-10-09
Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive Supranuclear Palsy(PSP), Dementia With Lewy Bodies (DLB)
Not yet recruitingBioSensics602027-01-152026-10-13
Relationship Between Anesthetic Regimen and Bone Cement Implantation Syndrome (BCIS)
Administration of general anaesthesia, Neuraxial Analgesia - Bone Cement Implantation Syndrome
Not applicableEnrolling by invitationJohns Hopkins University242027-01-102026-07-21
SniffTrain: Effectiveness of Sniff Training in the Treatment of Post-Viral Anosmia
Sniff Training Kits - Post-viral Anosmia, Anosmia
Not applicableNot yet recruitingUniversity of Virginia2042027-01-052026-10-05
Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure
HEROIC program, Active Comparator Control 1 - Heart Failure, Caregiver
Phase 2Not yet recruitingJohns Hopkins University5002027-01-042026-09-04
Accelerated Flap Coverage Versus Standard Timing in the Treatment of Severe Lower Extremity Musculoskeletal Injuries
Accelerated Flap Coverage Surgery, Standard of Care Flap Timing - Open Tibia Fracture, Open Dislocation of Ankle
Not applicableNot yet recruitingJohns Hopkins University3562027-01-012026-09-18
Voice Quality Analysis of Patients With Laryngotracheal Stenosis
Voice Biomarker Screening Too - Idiopathic Subglottic Tracheal Stenosis
Not yet recruitingJohns Hopkins University1002027-01-012026-07-13
Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs)
GentleMax Pro (with skin cooling), GentleMax Pro (without skin cooling) - Neurofibromatosis 1 (NF1), Neurofibromatosis Type I
Not applicableSuspendedMassachusetts General Hospital102027-01-012026-06-04
The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis
High-touch self-management program, Low-touch self-management program - Cirrhoses, Liver
Not applicableNot yet recruitingUniversity of Pennsylvania6252027-01-012026-10-02
Daridorexant for Alcohol Use Disorder
Daridorexant 50 mg, Placebo - Alcohol Use Disorder
Phase 2Not yet recruitingJohns Hopkins University1502027-01-012026-04-20
Brain Imaging of DSP-2342
DSP-2342 - SCHIZOPHRENIA 1 (Disorder)
Phase 2Not yet recruitingJohns Hopkins University202027-01-012026-09-30
Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
INTENT Neural Interface System - Tetraplegia/Tetraparesis, Amyotrophic Lateral Sclerosis (ALS)
Not applicableRecruitingJohns Hopkins University52027-01-012026-10-09
Racism-related Stress and Objective Short-sleep as Moderators of Treatment Effect in Cognitive Behavioral Therapy for Insomnia
Cognitive Behavioral Therapy for Insomnia (CBTi) - Insomnia, Stress
Not applicableNot yet recruitingJohns Hopkins University1002027-01-012026-09-10

Showing 20 of 2508. Sign in to see all of them.

Conditions studied

Hypertension (64)  ·  Obesity (64)  ·  Acquired Immunodeficiency Syndrome (63)  ·  Depression (53)  ·  HIV Infections (53)  ·  Cognitive Dysfunction (51)  ·  Substance-Related Disorders (51)  ·  Opioid-Related Disorders (49)  ·  Alzheimer Disease (45)  ·  Dementia (41)  ·  Anxiety Disorders (39)  ·  Breast Neoplasms (39)  ·  Diabetes Mellitus (39)  ·  Stroke (39)  ·  COVID-19 (36)

Interventions

Psilocybin (29)  ·  Standard of Care (24)  ·  Dronabinol (20)  ·  Saline Solution (20)  ·  Sodium Chloride (18)  ·  Cognitive Behavioral Therapy (16)  ·  Methods (16)  ·  Transcranial Direct Current Stimulation (16)  ·  nabiximols (16)  ·  Buprenorphine (15)  ·  Sugars (14)  ·  Surveys and Questionnaires (14)  ·  Therapeutics (13)  ·  Isoniazid (12)  ·  Azithromycin (11)

Countries

United States (2140)  ·  Canada (54)  ·  South Africa (36)  ·  India (33)  ·  Uganda (23)  ·  United Kingdom (22)  ·  Bangladesh (14)  ·  Brazil (14)  ·  Germany (14)  ·  Peru (14)  ·  Australia (12)  ·  China (12)  ·  Tanzania (11)  ·  Zambia (11)  ·  Malawi (10)

Top investigators

Madhav Thambisetty, MD, PhD (14)  ·  Ryan Vandrey, PhD (13)  ·  Steven P Cohen, MD (13)  ·  Kenneth Silverman, Ph.D. (11)  ·  Christine Durand, MD (9)  ·  Eric H Kossoff, MD (8)  ·  Jonathan Jun, MD (8)  ·  Kyrana Tsapkini, PhD (8)  ·  Robert Wood, MD (8)  ·  Tory Spindle, PhD (8)  ·  Alexander Pantelyat, MD (7)  ·  Charles Brown, MD (7)  ·  Craig Hendrix, MD (7)  ·  Mouen A Khashab, MD (7)  ·  Roland R Griffiths, Ph.D. (7)

Results publications

PMID 42560883, PMID 29281579, PMID 31723056, PMID 34453519, PMID 18565399, PMID 21087331, PMID 21782353, PMID 22041255, PMID 22267750, PMID 25022541, PMID 25858004, PMID 28007445, PMID 28292764, PMID 28800895, PMID 29747583, PMID 30340648, PMID 30352714, PMID 31643128, PMID 32628945, PMID 33079196, PMID 33760713, PMID 34057734, PMID 34242666, PMID 34255068, PMID 34937780, PMID 35042101, PMID 35314069, PMID 35579938, PMID 35724253, PMID 35998103, PMID 36094829, PMID 36208817, PMID 36716451, PMID 36907833, PMID 37287104, PMID 37318215, PMID 37379584, PMID 38094930, PMID 38236223, PMID 39240566, PMID 39252005, PMID 40303266, PMID 40342086, PMID 40780143, PMID 40970353, PMID 41995596, PMID 42054680, PMID 10382797, PMID 10493481, PMID 10604470

NIH funding

R01DA019934 (6), P50MH115842 (5), R01DA003890 (5), P50MD017348 (4), P30AG021334 (3), P30AI094189 (3), P30NR018093 (3), P50AA027054 (3), R01AG056587 (3), R01DA019497 (3), R01DA043475 (3), R01HL061912 (3), U01AI138897 (3), U19AI070345 (3), U19AI113127 (3)